Targeting FHL2 for EGFRvIII-positive glioblastoma.

Targeting FHL2 for EGFRvIII-positive glioblastoma.
Oncotarget. 2018 Dec 04;9(95):36730-36731
Authors: Sun L, Lan Q, Li M
PMID: 30613360 [PubMed]

Source: Oncotarget - January 8, 2019 Category: Cancer & Oncology Tags: Oncotarget Source Type: research